Subcutaneous Anifrolumab in Adult Patients With Lupus: A Promising Approach?
I recently came across a study titled 'Subcutaneous Anifrolumab in Adult Patients With Lupus' and I'm curious to hear what others think about its goals and outcomes. The study aims to evaluate the safety, efficacy, and pharmacokinetics of anifrolumab, a type I interferon receptor antagonist, adminis...